| 摘要 |
<p>1,200,337. Indole derivatives. J. R. GEIGY A.G. 28 Nov., 1967 [29 Nov., 1966], No. 53997/67. Heading C2C. The invention comprises indole derivatives of the general Formula I wherein R represents a hydrogen or halogen atom and R 1 represents 3-pyridyl or 4-pyridyl and their pharmaceutically acceptable acid addition salts with inorganic or organic acids. They are prepared by cyclizing by known methods a compound of the general formula wherein A represents hydrogen and B represents a phenylhydrazone group substituted in the 4-position according to the meaning of R above, or A represents an anilino group substituted in the 4-position according to the meaning of R and B represents oxygen, or A represents a 2-aminophenyl group substituted in the 5-position according to the meaning of R and B represents oxygen, and R 1 is as defined above, in the presence of a protonating agent, or by cyclizing by known methods a compound of the formula wherein R and R 1 are as defined above, in the presence of a protonating agent, and if desired converting the compounds of Formula I to their acid addition salts with inorganic or organic acids. 3 - Propionylpyridine 4 - chlorophenylhydrazone is prepared by reacting 4-chlorophenylhydrazine with 3-propionylpyridine. 4 - Propionylpyridine phenyl hydrazone is prepared by reacting 4 - propionylpyridine with phenyl hydrazine. 3 - [2 - (2 - amino phenyl) - propionyl] pyridine is prepared by reducing 3 - [2 - (2 - nitro phenyl) - propionyl]pyridine which is prepared by reacting 3-bromopyridine with ethyl 2-(2-nitrophenyl)- propionate and butyl-lithium. Pharmaceutical compositions comprising as active ingredients compounds of Formula I together with a pharmaceutically acceptable diluent or carrier are administered orally or parenterally and are used in the treatment of hyperaldosteronism.</p> |
